Legal & General Group
WHWK

Legal & General Group’s Whitehawk Therapeutics WHWK Stock Holding History

Legal & General Group’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.5K Buy
+3,162
New +$13.2K ﹤0.01% 3235
2024
Q2 		– Sell
-1,484
Closed -$3.47K – 3526
2024
Q1 		$3.47K Hold
1,484
– – ﹤0.01% 3322
2023
Q4 		$3K Hold
1,484
– – ﹤0.01% 3349
2023
Q3 		$7.18K Hold
1,484
– – ﹤0.01% 3327
2023
Q2 		$10.2K Sell
1,484
-341
-19% -$2.65K ﹤0.01% 3319
2023
Q1 		$13.2K Hold
1,825
– – ﹤0.01% 3158
2022
Q4 		$23.4K Buy
1,825
+267
+17% +$3.49K ﹤0.01% 3118
2022
Q3 		$22K Sell
1,558
-1,217
-44% -$16K ﹤0.01% 3186
2022
Q2 		$34K Buy
+2,775
New +$41.2K ﹤0.01% 3086

Other funds holding WHWK

YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Legal & General Group's WHWK Position: Q2 2026 in Review

Legal & General Group opened a new position in Whitehawk Therapeutics (WHWK) in Q2 2026: 3,162 shares worth $14.5K. The stake represents ﹤0.01% of the portfolio and ranks #3235 among its holdings. This is a return to the name: Legal & General Group previously reported a position in WHWK as recently as Q1 2024.

Legal & General Group first reported a position in WHWK in Q2 2022 and has held it in 9 quarters since. The position peaked at $34K in Q2 2022. 78 funds tracked by Wall St. Rank hold WHWK as of Q2 2026.

  • Legal & General Group held 3,162 shares of Whitehawk Therapeutics worth $14.5K as of Q2 2026.
  • Whitehawk Therapeutics was a new Legal & General Group position in Q2 2026.
  • Whitehawk Therapeutics made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #3235 holding.
  • Legal & General Group first reported a position in Whitehawk Therapeutics in Q2 2022 and has held it in 9 quarters since.
  • Legal & General Group's Whitehawk Therapeutics position peaked at $34K in Q2 2022.
  • 78 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.